<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30099223</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-0852</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>102</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>European journal of cancer (Oxford, England : 1990)</Title>                <ISOAbbreviation>Eur. J. Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry.</ArticleTitle>            <Pagination>                <MedlinePgn>1-9</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0959-8049(18)30954-7</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejca.2018.07.004</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Brain metastases (BMs) have a major impact on life expectancy and quality of life for many breast cancer patients. Knowledge about treatment patterns and outcomes is limited.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We analysed clinical data of 1712 patients diagnosed with BMs from breast cancer between January 2000 and December 2016 at 80 institutions.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Median age at diagnosis of BMs was 56 years (22-90 years). About 47.8% (n = 732) of patients had HER2-positive, 21.4% (n = 328) had triple-negative and 30.8% (n = 471) had hormone receptor (HR)-positive, HER2-negative (luminal-like) primary tumours. The proportion of patients with HER2-positive BMs decreased comparing the years 2000-2009 with 2010-2015 (51%-44%), whereas the percentage of patients with luminal-like tumours increased (28%-34%; p = 0.0331). Patients with BMs in the posterior fossa were more often HER2 positive (n = 169/314, 53.8%) than those diagnosed with triple-negative (n = 65/314, 20.7%) or luminal-like primary breast cancer (n = 80/314, 25.5%), (p &lt; 0.0001). Median overall survival (OS) time after development of BMs for the overall cohort was 7.4 months (95% confidence interval [CI]: 6.7-8.0 months). One-year survival rate was 37.7% (95% CI: 35.2-40.1). Patients with HER2-positive tumours had the longest median OS of 11.6 months (95% CI: 10.0-13.4) compared with 5.9 months (95% CI: 5.0-7.2) for patients with luminal-like and 4.6 months (95% CI: 3.9-5.4) for patients with triple-negative tumours. Patients with HER2-positive tumours who received anti-HER2 treatment had longer median OS than those without (17.1 months versus 7.2 months, p &lt; 0.0001).</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prognosis of patients after developing BMs varies significantly according to the subtype. The outcome in this cohort is similarly poor in triple-negative and HR-positive/HER2-negative patients. Our results underline the high medical need for improvement of treatment and prevention strategies for BMs in breast cancer patients.</AbstractText>                <CopyrightInformation>Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Witzel</LastName>                    <ForeName>I</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany. Electronic address: iwitzel@uke.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Laakmann</LastName>                    <ForeName>E</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany. Electronic address: e.laakmann@uke.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weide</LastName>                    <ForeName>R</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Oncological Outpatient Department, Koblenz, Germany. Electronic address: weide@onkologie-koblenz.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Neunhöffer</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>HELIOS Dr. Horst Schmidt Clinic Wiesbaden, Wiesbaden, Germany. Electronic address: Tanja.Neunhoeffer@helios-gesundheit.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Park-Simon</LastName>                    <ForeName>T-J</ForeName>                    <Initials>TJ</Initials>                    <AffiliationInfo>                        <Affiliation>Hannover Medical School, Department of Gynecology, Hannover, Germany. Electronic address: Park-Simon.tjoung-won@mh-hannover.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schmidt</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gynecology, University Medical Center of the Johannes Gutenberg University Mainz, Germany. Electronic address: marcus.schmidt@unimedizin-mainz.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fasching</LastName>                    <ForeName>P A</ForeName>                    <Initials>PA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. Electronic address: Peter.Fasching@uk-erlangen.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hesse</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Agaplesion Diakonie Clinic Rotenburg, Department of Gynecology, Rotenburg, Germany. Electronic address: Hesse@diako-online.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Polasik</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gynecology and Obstetrics, University Medical Center Ulm, Germany. Electronic address: arkadius.polasik@uniklinik-ulm.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mohrmann</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Duesseldorf University Hospital, Department of Gynecology, Duesseldorf, Germany. Electronic address: svjetlana.mohrmann@med.uni-duesseldorf.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Würschmidt</LastName>                    <ForeName>F</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Radiologische Allianz Hamburg, Hamburg, Germany. Electronic address: florian.wuerschmidt@radiologische-allianz.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schem</LastName>                    <ForeName>C</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>University Medical Center-UKSH, Department of Gynecology, Kiel, Germany; Mammazentrum, Krankenhaus Jerusalem, Hamburg, Germany. Electronic address: schem@mammazentrum.eu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bechtner</LastName>                    <ForeName>C</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Frauenklinik, Memmingen Hospital, Germany. Electronic address: christina.bechtner@klinikum-memmingen.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Würstlein</LastName>                    <ForeName>R</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gynecology and Obstetrics, Ludwig-Maximilian-University Munich, Germany. Electronic address: Rachel.Wuerstlein@med.uni-muenchen.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fehm</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Translational Research Board of the Gynecological Oncology Working Group (AGO-Trafo), Germany. Electronic address: tanja.fehm@med.uni-duesseldorf.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Möbus</LastName>                    <ForeName>V</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Study Group of the Gynecological Oncology Working Group (AGO-B), Germany. Electronic address: Volker.Moebus@KlinikumFrankfurt.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Burchardi</LastName>                    <ForeName>N</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>German Breast Group GmbH, Neu-Isenburg, Germany. Electronic address: Nicole.Burchardi@gbg.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Loibl</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>German Breast Group GmbH, Neu-Isenburg, Germany. Electronic address: sibylle.loibl@gbg.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Müller</LastName>                    <ForeName>V</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany. Electronic address: vmueller@uke.de.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>09</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Eur J Cancer</MedlineTA>            <NlmUniqueID>9005373</NlmUniqueID>            <ISSNLinking>0959-8049</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Brain metastases</Keyword>            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Diagnostic procedures</Keyword>            <Keyword MajorTopicYN="N">Survival</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>02</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30099223</ArticleId>            <ArticleId IdType="pii">S0959-8049(18)30954-7</ArticleId>            <ArticleId IdType="doi">10.1016/j.ejca.2018.07.004</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>